LeMaitre Vascular, Inc. (LMAT)

84.34 +0.37 (+0.44%) USD  |  NASDAQ  |  Dec 24, 16:00
More

LeMaitre Vascular Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for LMAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Baxter International, Inc. Upgrade
Integra LifeSciences Holdings Corp. Upgrade
ResMed, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade